ALZN stock forecast
Our latest prediction for Alzamend Neuro Inc's stock price was made on the Dec. 29, 2023 when the stock price was at 0.89$.
In the short term (2weeks), ALZN's stock price should underperform the market by -2.23%. During that period the price should oscillate between -10.63% and +9.94%.
In the medium term (3months), ALZN's stock price should underperform the market by -14.94%. During that period the price should oscillate between -37.94% and +21.28%.
Get email alertsCreate a solid portfolio with ALZN
About Alzamend Neuro Inc
alzamend neuro is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of alzheimer’s disease, bipolar disorder, major depressive disorder (“mdd”) and post-traumatic stress disorder (“ptsd”). our mission is to rapidly develop and market safe and effective treatments to bring aid to the 43+ million americans suffering from these debilitating diseases. our current pipeline consists of two novel therapeutic drug candidates, al001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and alzn002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient’s immunological system to combat alzheimer’s.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.57$ per share.
The book value per share is -0.02$
Three months stock forecastDec. 29, 2023
Financials
Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
---|---|---|---|---|---|---|---|---|---|---|---|---|
- | - | -14M | - | -14M | -0.57 | - | - | 6M | -0.02 | - | - | - |